We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ENI:MILEni S.p.A. Analysis

Data as of 2026-03-10 - not real-time

€20.64

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: ENI is trading in a bullish environment with the 20‑day SMA above both the 50‑day and 200‑day averages, and the MACD line sitting above its signal, indicating momentum to the upside. The RSI is deep in overbought territory, suggesting short‑term price pressure, while volume is on an upward trend and the price is hugging a key resistance near the recent high. The nearest support sits just below the current level, providing a cushion if the market tests it. Valuation signals show a DCF‑derived fair value far above the market price, implying a material discount, even though the trailing P/E exceeds the industry average. The dividend yield remains robust, but the payout ratio is above 100% and free cash flow is negative, raising questions about sustainability.
Fundamental backdrop: Revenue has contracted year‑over‑year and margins are thin, with operating and profit margins under 5% and 3% respectively. Leverage is elevated, reflected in a debt‑to‑equity ratio above 60%, and return metrics (ROE, ROA) are modest. The stock’s beta is low, yet 30‑day volatility is high, and the energy sector faces pronounced commodity and transition risks, amplified by stringent EU regulatory pressures. Given the attractive dividend, the valuation gap, and the ongoing shift toward renewables, the medium‑term case leans toward a buying opportunity, while short‑term caution and long‑term regulatory headwinds suggest a more measured stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought zone
  • Bullish MACD but price near resistance
  • Upcoming ex‑dividend date

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value indicates sizable discount
  • High dividend yield relative to peers
  • Improving forward P/E versus current valuation

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Energy transition and regulatory headwinds
  • Elevated leverage and modest ROE
  • Dividend sustainability concerns despite attractive yield

Key Metrics & Analysis

Financial Health

Revenue Growth-12.20%
Profit Margin3.12%
P/E Ratio26.5
ROE5.09%
ROA2.90%
Debt/Equity64.79
P/B Ratio1.3
Op. Cash Flow€13.3B
Free Cash Flow€-8550750208
Industry P/E20.6

Technical Analysis

TrendBullish
RSI75.2
Support€17.92
Resistance€21.10
MA 20€19.23
MA 50€17.74
MA 200€15.65
MACDBullish
VolumeIncreasing
Fear & Greed Index79.63

Valuation

Fair Value€37.36
Target Price€19.09
Upside/Downside-7.50%
GradeUndervalued
TypeValue
Dividend Yield4.95%

Risk Assessment

Beta0.23
Volatility19.50%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.